Publication | Open Access
The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer
28
Citations
17
References
2019
Year
Our data suggest that Foxy5 can complement the traditional adjuvant chemotherapeutic treatment to which CSCs are resistant.
| Year | Citations | |
|---|---|---|
Page 1
Page 1